this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->

ASW

N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide

ASW is found in 1 entry

ASW as free ligands, exist in 1 entry. Example includes: 4G0U

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

NameN-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide
IdentifiersN-[4-(acridin-9-ylamino)-3-methoxy-phenyl]methanesulfonamide
FormulaC21 H19 N3 O3 S
Molecular Weight393.46 g/mol
TypeNON-POLYMER
Isomeric SMILESCOc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12
InChIInChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)
InChIKeyXCPGHVQEEXUHNC-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count47
Chiral Atom Count0
Chiral Atomsn/a
Bond Count50
Aromatic Bond Count22
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00276 Different stereochemistry
NameAmsacrine
Groupsapproved
DescriptionAminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects. [PubChem]
Synonyms
  • 4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide
  • 4'-(9-Acridinylamino)methanesulfon-m-anisidide
  • 4'-(9-Acridinylamino)methanesulfon-meta-anisidide
  • 4'-(9-Acridinylamino)methanesulphon-m-anisidide
  • Acridinyl anisidide
Salts
  • Amsacrine gluconate
  • Amsacrine hydrochloride
  • Amsacrine mesylate
Brand Names
  • Amsa Pd Inj 50mg/ml
  • AMSA P-D
  • Amekrin
  • Amsidine
  • Amsidyl
Affected OrganismHumans and other mammals
IndicationFor treatment of acute myeloid leukaemia.
PharmacologyAmsacrine is an aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects.
Mechanism of actionAmsacrine binds to DNA through intercalation and external binding. It has a base specificity for A-T pairs. Rapidly dividing cells are two to four times more sensitive to amsacrine than are resting cells. Amsacrine appears to cleave DNA by inducing double stranded breaks. Amsacrine also targets and inhibits topoisomerase II. Cytotoxicity is greatest during the S phase of the cell cycle when topoisomerase levels are at a maximum.
Route of administrationIntravenous
Categories
  • Acridines
  • Aminoacridines
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • Chemical Actions and Uses
ATC-CodeL01XX01
AHFS-Code10:00.00
CAS number51264-14-3
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682